======= SOX12 ======= == Gene Information == * **Official Symbol**: SOX12 * **Official Name**: SRY-box transcription factor 12 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6666|6666]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15370|O15370]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SOX12&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOX12|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601947|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to the sequence 5'-AACAAT-3'. {ECO:0000250}. |HMG box| |nuclear transcription factor complex| |protein-DNA complex| |transcription regulatory region sequence-specific DNA binding| |spinal cord development| |protein-DNA complex assembly| |protein-DNA complex subunit organization| |cell fate commitment| |transcription coactivator activity| |DNA-binding transcription activator activity, RNA polymerase II-specific| |cellular protein-containing complex assembly| |central nervous system development| |positive regulation of transcription by RNA polymerase II| |DNA binding| |positive regulation of transcription, DNA-templated| |protein-containing complex assembly| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.35| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.98| |[[:results:exp116|AICAR 240μM R03 exp116]]|-1.75| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.75| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.76| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|1.77| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.79| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.96| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|2.01| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|2.07| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|2.15| |[[:results:exp518|RK-33 8μM R08 exp518]]|2.2| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15950 * **Expression level (log2 read counts)**: 6.12 {{:chemogenomics:nalm6 dist.png?nolink |}}